NCT07073404View on ClinicalTrials.gov

Omalizumab for Plant-Food Allergy Due to Sensitization to LTP or Profilin

Not yet recruitingOBSERVATIONAL
Enrollment

37

Participants

Timeline

Start Date

January 31, 2026

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions
Food Allergies
Interventions
DRUG

Omalizumab Injection

Treatment with omalizumab in monotherapy for 16 weeks in patients allergic to vegetables due to sensitization to lipid transfer proteins (LTPs) and profilin.

All Listed Sponsors
collaborator

Institute of Biomedical Research in Málaga (IBIMA)

UNKNOWN

lead

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

OTHER

NCT07073404 - Omalizumab for Plant-Food Allergy Due to Sensitization to LTP or Profilin | Biotech Hunter | Biotech Hunter